Rhodiola crenulata extract for prevention of acute mountain sickness: A randomized, double-blind, placebo-controlled, crossover trial

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Chiu, Te Fa ^a,b   Chen, Lisa Li Chuan ^a   Su, Deng Huang ^c,d   Lo, Hsiang Yun ^a,b   Chen, Chung Hsien ^a   Wang, Shih Hao ^e,f   Chen, Wei Lung ^g,h  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c Far east Polyclinics ^*  (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL TAITUNG UNIVERSITY   (Taiwan)

^g CATHAY GENERAL HOSPITAL   (Taiwan)

^h FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Acute mountain sickness; High altitude illness; Rhodiola

Indexed keywords

PLANT EXTRACT; RHODIOLA CRENULATA PLANT EXTRACT; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ADULT; ALTITUDE DISEASE; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; HEART PALPITATION; HUMAN; INCIDENCE; MICTURITION; MOUNTAINEERING; NORMAL HUMAN; OUTCOME ASSESSMENT; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHODIOLA; RHODIOLA CRENULATA; SIDE EFFECT; SLEEP DISORDER; XEROSTOMIA;

ACUTE DISEASE; ADULT; ALTITUDE SICKNESS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLANT EXTRACTS; RHODIOLA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84886736889     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-298     Document Type: Article

References (41)

1. Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001, 345(2):107-114. 10.1056/NEJM200107123450206, 11450659.
2. Imray C, Booth A, Wright A, Bradwell A. Acute altitude illnesses. BMJ 2011, 343:d4943. 10.1136/bmj.d4943, 21844157.
3. Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Arch Intern Med 2005, 165(3):296-301. 10.1001/archinte.165.3.296, 15710792.
4. Hackett PH, Rennie D, Levine HD. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976, 2(7996):1149-1155.
5. Seupaul RA, Welch JL, Malka ST, Emmett TW. Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review. Ann Emerg Med 2012, 59(4):307-317. 10.1016/j.annemergmed.2011.10.015, 22153998.
6. Basnyat B, Murdoch DR. High-altitude illness. Lancet 2003, 361(9373):1967-1974. 10.1016/S0140-6736(03)13591-X, 12801752.
7. Dumont L, Mardirosoff C, Tramer MR. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ 2000, 321(7256):267-272. 10.1136/bmj.321.7256.267, 27441, 10915127.
8. Basnyat B, Gertsch JH, Holck PS, Johnson EW, Luks AM, Donham BP, Fleischman RJ, Gowder DW, Hawksworth JS, Jensen BT, et al. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. High Alt Med Biol 2006, 7(1):17-27. 10.1089/ham.2006.7.17, 16544963.
9. Imray C, Wright A, Subudhi A, Roach R. Acute mountain sickness: pathophysiology, prevention, and treatment. Prog Cardiovasc Dis 2010, 52(6):467-484. 10.1016/j.pcad.2010.02.003, 20417340.
10. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 2010, 17(7):481-493. 10.1016/j.phymed.2010.02.002, 20378318.
11. Gertsch JH, Seto TB, Mor J, Onopa J. Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent. High Alt Med Biol 2002, 3(1):29-37. 10.1089/152702902753639522, 12006162.
12. Gertsch JH, Basnyat B, Johnson EW, Onopa J, Holck PS. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ 2004, 328(7443):797. 10.1136/bmj.38043.501690.7C, 383373, 15070635.
13. van Patot MC, Keyes LE, Leadbetter G, Hackett PH. Ginkgo biloba for prevention of acute mountain sickness: does it work?. High Alt Med Biol 2009, 10(1):33-43. 10.1089/ham.2008.1085, 19278351.
14. Zhang ZJ, Tong Y, Zou J, Chen PJ, Yu DH. Dietary supplement with a combination of Rhodiola crenulata and Ginkgo biloba enhances the endurance performance in healthy volunteers. Chin J Integr Med 2009, 15(3):177-183. 10.1007/s11655-009-0177-x, 19568709.
15. Abidov M, Crendal F, Grachev S, Seifulla R, Ziegenfuss T. Effect of extracts from Rhodiola rosea and Rhodiola crenulata (Crassulaceae) roots on ATP content in mitochondria of skeletal muscles. Bull Exp Biol Med 2003, 136(6):585-587.
16. Li T, Zhang H. Identification and comparative determination of rhodionin in traditional tibetan medicinal plants of fourteen Rhodiola species by high-performance liquid chromatography-photodiode array detection and electrospray ionization-mass spectrometry. Chem Pharm Bull (Tokyo) 2008, 56(6):807-814. 10.1248/cpb.56.807, 18520085.
17. Salazar H, Swanson J, Mozo K, White AC, Cabada MM. Acute mountain sickness impact among travelers to Cusco. Peru. J Travel Med 2012, 19(4):220-225.
18. De Bock K, Eijnde BO, Ramaekers M, Hespel P. Acute Rhodiola rosea intake can improve endurance exercise performance. Int J Sport Nutr Exerc Metab 2004, 14(3):298-307.
19. Hung SK, Perry R, Ernst E. The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine 2011, 18(4):235-244. 10.1016/j.phymed.2010.08.014, 21036578.
20. Lee SY, Li MH, Shi LS, Chu H, Ho CW, CTC Rhodiola crenulata extract alleviates hypoxic pulmonary edema in rats. Evid Based Complement Alternat Med 2013, 2013:718739. 3655596, 23710233, CTC.
21. Swenson ER, Maggiorini M, Mongovin S, Gibbs JSR, Greve I, Mairbäurl H, Bärtsch P. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 2002, 287(17):2228-2235. 10.1001/jama.287.17.2228, 11980523.
22. Stream JO, Grissom CK. Update on high-altitude pulmonary edema: pathogenesis, prevention, and treatment. Wilderness Environ Med 2008, 19(4):293-303. 10.1580/07-WEME-REV-173.1, 19099331.
23. Icard P, Saumon G. Alveolar sodium and liquid transport in mice. Am J Physiol 1999, 277(6):L1232-L1238.
24. Looney MR, Sartori C, Chakraborty S, James PF, Lingrel JB, Matthay MA. Decreased expression of both the α1-and α2 -subunits of the Na-K-ATPase reduces maximal alveolar epithelial fluid clearance. Am J Physiol 2005, 289(1):L104-L110.
25. Zhang BC, Li WM, Guo R, Xu YW. Salidroside decreases atherosclerotic plaque formation in low-density lipoprotein receptor-deficient mice. Evid Based Complement Alternat Med 2012, 2012:607508. 3474264, 23093983.
26. Sun L, Isaak CK, Zhou Y. Salidroside and Tyrosol from Rhodiola protect H9c2 cell from ischemia/reperfusion-induced apoptosis. Life Sci 2012, 91:151-158. 10.1016/j.lfs.2012.06.026, 22771701.
27. Chen SF, Tsai HJ, Hung TH, Chen CC, Lee CY, Wu CH, Wang PY, Liao NC. Salidroside improves behavioral and histological outcomes and reduces apoptosis via PI3K/Akt signaling after experimental traumatic brain injury. PLoS One 2012, 7(9):e45763. 10.1371/journal.pone.0045763, 3454376, 23029230.
28. Tu Y, Roberts L, Shetty K, Schneider SS. Rhodiola crenulata induces death and inhibits growth of breast cancer cell lines. J Med Food 2008, 11(3):413-423. 10.1089/jmf.2007.0736, 18800886.
29. Lee OH, Kwon YI, Apostolidis E, Shetty K, Kim YC. Rhodiola-induced inhibition of adipogenesis involves antioxidant enzyme response associated with pentose phosphate pathway. Phytother Res 2011, 25(1):106-115. 10.1002/ptr.3236, 20623718.
30. Qu ZQ, Zhou Y, Zeng YS, Lin YK, Li Y, Zhong ZQ, Chan WY. Protective effects of a Rhodiola crenulata extract and salidroside on hippocampal neurogenesis against streptozotocin-induced neural injury in the rat. PLoS One 2012, 7(1):e29641. 10.1371/journal.pone.0029641, 3250459, 22235318.
31. Lee SY, Shi LS, Chu H, Li MH, Ho CW, Lai FY, Huang CY, Chang TC. Rhodiola crenulata and its bioactive components, salidroside and tyrosol, reverse the hypoxia-induced reduction of plasma-membrane-associated Na. K-ATPase expression via inhibition of ROS-AMPK-PKC ξ Pathway. Evid Based Complement Alternat Med 2013, 2013:284150.
32. Wu TY, Ding SQ, Zhang SL, Duan JQ, Li BY, Zhan ZY, Wu QL, Baomu S, Liang BZ, Han SR, Jie YL, Li G, Sun L, Kayser B. Altitude illness in Qinghai-Tibet railroad passengers. High Alt Med Biol 2010, 11(3):189-198. 10.1089/ham.2009.1047, 20919885.
33. Wang S, Wang FP. [Studies on the chemical components of Rhodiola crenulata]. Yao Xue Xue Bao 1992, 27(2):117-120.
34. Wang S, You XT, Wang FP. [HPLC determination of salidroside in the roots of Rhodiola genus plants]. Yao Xue Xue Bao 1992, 27(11):849-852.
35. Roach RC, Bartsch P, Hackett PH, Oelz O. Hypoxia and Molecular Medicine: Proceedings of the 8th International Hypoxia Symposium: The Lake Louise Acute Mountain Sickness Scoring System 1993,
36. Wang SH, Chen YC, Kao WF, Lin YJ, Chen JC, Chiu TF, Hsu TY, Chen HC, Liu SW. Epidemiology of acute mountain sickness on Jade Mountain, Taiwan: an annual prospective observational study. High Alt Med Biol 2010, 11(1):43-49. 10.1089/ham.2009.1063, 20367488.
37. Mairer K, Wille M, Bucher T, Burtscher M. Prevalence of acute mountain sickness in the Eastern Alps. High Alt Med Biol 2009, 10(3):239-245. 10.1089/ham.2008.1091, 19775213.
38. Pesce C, Leal C, Pinto H, González G, Maggiorini M, Schneider M, Bärtsch P. Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m). High Alt Med Biol 2005, 6(2):158-166. 10.1089/ham.2005.6.158, 16060850.
39. Ziaee V, Yunesian M, Ahmadinejad Z, Halabchi F, Kordi R, Alizadeh R, Afsharjoo HR. Acute mountain sickness in Iranian trekkers around Mount Damavand (5671 m) in Iran. Wilderness Environ Med 2003, 14(4):214-219. 10.1580/1080-6032(2003)14[214:AMSIIT]2.0.CO;2, 14719853.
40. Gaillard S, Dellasanta P, Loutan L, Kayser B. Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up. High Alt Med Biol 2004, 5:410-419. 10.1089/ham.2004.5.410, 15671630.
41. Vardy J, Vardy J, Judge K. Can knowledge protect against acute mountain sickness?. J Public Health (Oxf) 2005, 27:366-370. 10.1093/pubmed/fdi060, 16234261.